Trulieve Cannabis Corp
General ticker "TCNNF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.0B
Trulieve Cannabis Corp does not follow the US Stock Market performance with the rate: -4.7%.
Estimated limits based on current volatility of 3.4%: low 4.68$, high 5.02$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.93$, 6.50$]
- 2024-12-30 to 2025-12-30 estimated range: [3.28$, 6.91$]
Financial Metrics affecting the TCNNF estimates:
- Negative: Non-GAAP EPS, $ of -1.17 <= 0.10
- Negative: Operating profit margin, % of -16.41 <= 1.03
- Positive: Operating cash flow per share per price, % of 19.71 > 12.76
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.64 <= 1.08
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.20
Short-term TCNNF quotes
Long-term TCNNF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $938.38MM | $1,239.81MM | $1,129.19MM |
| Operating Expenses | $741.44MM | $1,207.40MM | $1,350.81MM |
| Operating Income | $196.95MM | $32.41MM | $-221.61MM |
| Non-Operating Income | $-33.44MM | $-75.75MM | $-62.92MM |
| Interest Expense | $34.79MM | $79.80MM | $81.57MM |
| Income(Loss) | $163.51MM | $-43.34MM | $-284.54MM |
| Taxes | $146.06MM | $161.82MM | $151.36MM |
| Other Income(Loss) | $0.00MM | $-47.56MM | $-97.24MM |
| Profit(Loss) | $17.45MM | $-252.73MM | $-533.14MM |
| Stockholders Equity | $2,147.37MM | $1,927.70MM | $1,408.61MM |
| Assets | $3,410.87MM | $3,400.41MM | $2,729.05MM |
| Operating Cash Flow | $12.90MM | $23.10MM | $201.84MM |
| Capital expenditure | $306.12MM | $184.58MM | $55.49MM |
| Investing Cash Flow | $-215.18MM | $-215.06MM | $-37.47MM |
| Financing Cash Flow | $289.23MM | $177.80MM | $-175.59MM |
| Earnings Per Share* | $0.13 | $-1.10 | $-2.84 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.